Examples of 'natalizumab' in a sentence
Meaning of "natalizumab"
Natalizumab is a medication used to treat certain types of multiple sclerosis by decreasing inflammation in the body
Show more definitions
- A humanized monoclonal antibody used in the treatment of multiple sclerosis and Crohn's disease.
How to use "natalizumab" in a sentence
Basic
Advanced
natalizumab
Currently patient is using natalizumab to replace interferon.
Natalizumab effects on immune cell responses in multiple sclerosis.
Hypersensitivity to natalizumab or to any of the excipients.
Natalizumab in the treatment of multiple sclerosis.
Examples of this are natalizumab and infliximab.
Natalizumab and azathioprine maintain remission.
It contains the active substance natalizumab.
Mitoxantrone and natalizumab are believed to act as immunesuppressants.
Any prior treatment with natalizumab.
Treatment with natalizumab was generally well tolerated.
Another potential secondary agent is natalizumab.
Natalizumab is excreted in human milk.
The occurrence of malignancy during natalizumab treatment was uncommon.
Natalizumab prevents immune cells from reaching the brain.
The active substance is natalizumab.
See also
Natalizumab for use in treating diseases needing steroid treatment.
Therapeutic drug monitoring of natalizumab.
Natalizumab should not be used during pregnancy unless clearly necessary.
Methods of treating inflammatory and autoimmune diseases with natalizumab.
Natalizumab and fingolimod.
Method of risk management for patients undergoing natalizumab treatment.
Natalizumab is used as a monotherapy.
The assay diluent containing added natalizumab represented a confirmatory step.
This information provides a setting wherein appropriate patients receive natalizumab.
Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function.
Natalizumab and azathioprine were favored over placebo across the maintenance outcomes.
There are no adequate data from the use of natalizumab in pregnant women.
Antibodies that bound natalizumab that were present in biological samples from subjects.
Development of these persistent antibodies would be an indication for cessation of natalizumab therapy.
Treatment of adolescent patients with natalizumab demonstrates an effectiveness similar to that of adult patients.
The incidence of malignancy was balanced between the natalizumab and control groups.
Exposure to both natalizumab and interferons was associated with lower length and weight of babies.
Starting other therapies during this interval will result in a concomitant exposure to natalizumab.
The patients who received natalizumab died of alcohol intoxication and metastatic malignant melanoma.
No vedolizumab clinical trial data are available for patients previously treated with natalizumab.
Dozens of patients receiving treatment with natalizumab have been diagnosed with PML.
Disease exacerbations or infusion related events may indicate the development of antibodies against natalizumab.
Treatment with natalizumab appeared safe and well tolerated by subjects with active CD.
No vedolizumab clinical trial data are available for patients previously treated with natalizumab or rituximab.
Clinical Efficacy The efficacy of natalizumab was demonstrated in three studies.
Asymptomatic reactivation of JC virus in patients treated with natalizumab.
Methods of Treatment Pharmaceutical compositions of natalizumab will be administered intravenously.
PML was then treated with plasma exchange to accelerate removal of natalizumab.
Efficacy of Natalizumab Multiple Sclerosis MS is a chronic disease of the brain and spinal cord.
Comparisons were made between the placebo group and the two natalizumab dosing groups.
The effect of natalizumab on newborn / infants is unknown.
The first monoclonal antibody approved for MS is natalizumab.
Natalizumab for relapsing-remitting multiple sclerosis in adults.
There is no clinical trial experience with Entyvio in patients previously treated with natalizumab.
Administering a first dose of natalizumab for a first dosage period ;.
